Combined functional additives for farm animals are an important segment in the implementation of the antibiotic resistance strategy and an effective mechanism for restoring animal homeostasis in mixed pathologies
https://doi.org/10.32634/0869-8155-2021-354-11-12-8-17
Abstract
The article provides an overview of the global situation related to the problem of antibiotic resistance, the search for rational ways to solve the problem and proposals for the imperative introduction of functional feed additives into the nutritional plan of animals in order to increase the resistance of the animal body and reduce the toxic load on the gastrointestinal and hepatobiliary systems.
About the Authors
T. V. Sevastianova
Federal State Budgetary Educational Institution of Higher Education “Novosibirsk State Agrarian University”
Russian Federation
Russian Federation
Sevastyanova Tatyana Vladimirovna, Candidate Veterinary
Science, Associate Professor of the Department of Pharmacology
and General Pathology
630093, Novosibirsk, 160, Dobrolyubova st.
B. V. Usha
Institute of Veterinary Medicine, Veterinary and Sanitary Expertise and Agro-safety FSBEI HE MGUPP
Russian Federation
Russian Federation
Usha Boris Veniaminovich, Academician of the Russian Academy
of Sciences, Doctor of Veterinary Sciences, Professor, Director
109316, Moscow, st. Talalikhina, 33
References
1. Chattopadhyay M.K., 2014; Ardolino M., 2014; Done H.Y., 2015; Thevenot P.T., 2014; Sun Z., 2017.
2. O’Neill J. The Review on antimicrobial resistance. Tackling a crisis for the health and wealth of nations. December 2014. Available from: http://amr-review.org/.
3. The fifth ESVAC report, 2014.
4. EFSA and ECDC. The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015.
5. Fernández L., Hancock R. E. W. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance // Clin Microbiol Rev. — 2012. — Vol. 25. — No. 4. — P. 661–681.
6. Abebe E., Tegegne B. and Tibebu S. A Review on molecular mechanisms of bacterial resistance to antibiotics // European Journal of Applied Sciences. — 2016. — Vol. 8. — No. 5. — P. 301– 310.
7. Kapoor G., Saigal S., Elongavan A. Action and resistance mechanisms of antibiotics: A guide for clinicians // J Anaesthesiol Clin Pharmacol. — 2017. — Vol. 33. — Issue 3. — Р. 300–3056, 2.
8. Munita J. M., Cesar A. Mechanisms of antibiotic resistance // Microbiol Spectr. — 2016. — Vol. 4. — No. 2. — P. 10–48.
9. Von Wintersdorff et al. Front Microbiol. 2016. Feb 19. No. 7. Р. 173.
10. Danilov A.I., Kozlov R.S., Kozlov S.N., Dekhnich A.V. Management of patients with infectious endocarditis in the Russian Federation. Antibiotics and chemotherapy 2017; 1-2: 30- 4(In Russ)
11. Subbotin V.V., Danilevskaya N.V. Antibacterial therapy in veterinary practice. VetPharma 2011;1:38-42.(In Russ).
12. Kudmagambetov I.R., Sarsenbaeva S.S., Ramazanova S.H., Yesimova N.K. Modern approaches to control and deter antibiotic resistance in the world. International Journal of Applied and Basic Research 2015; 9-1: 54-9. (In Russ).
13. Akimkin V.G., Darbeeva O.S., Kolkov V.F. Bacteriophages: historical and modern aspects of their application: experience and prospects. Clinical practice 2010; 4 (4): 48-54. (In Russ).
14. Intestinal dysbiosis. Manual on diagnosis and treatment/edited by E.I. Tkachenko, A.N. Suvorov. - St. Petersburg: SpetsLit, 2007. – The 238th page 2. (In Russ).
15. E.I. Tkachenko, Yu.P. Uspensky. Food, microbiocenosis and intelligence of the person. – SPb.: SpetsLit, 2006. – 590 pages; B.A. Shenderov. Medical microbic ecology and functional food. T. 1. – M.: Grant’, 1988. – Page 246-285.(In Russ).
16. Fuller R., Gibson G. Probiotics and prebiotics: microflora management for improved gut health // Clin. Microbial. Infect. – 1998; 4: 477–480.
17. Hickson M. Probiotics in the prevention of antibioticassociated diarrhoea and Clostridium difficile infection // Therap. Adv. Gastroenterol. – 2011; 4 (3): 185–197.
18. Vanbelle M., Teller E., Focant M. (1990). Probiotics in animal nutrition: a review. Arch. Tierernahr. 40 (7), 543–567;2].
19. Kremenchutsky G.N., Ryzhenko S.A., Volyansky A.Yu., Molchanov R.N., Chuiko V.I. A-bacterin in the treatment and prevention of purulent and inflammatory processes. Dnepropetrovsk: Thresholds, 2000. — 150 s1 (In Russ).
20. Miller M.B. and B.L. Bassler. 2001. Quorum sensing in bacteria. Annu Rev Microbiol. 55:165- 199.
21. Hughes, D.T. & Sperandio, V. 2008. Inter-kingdom signalling: communication between bacteria and their hosts. Nature Reviews in Microbiology, 6(2): 111–120.
22. Medellin-Penna, M.J., Wang, H.Jonson, R. Anand S. and Griffiths M.W., 2007. Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl. environ. Microbiol., 73:4259-4267.
23. Shrago, A., Chassy, B. & Dobrogosz, W. 1986. Conjugal plasmid transfer (pAM beta 1) in Lactobacillus plantarum. Applied and Environmental Microbiology, 52(3): 574–576.
24. Mountzouris, K., Tsitrsikos, P., Palamidi, I., Arvaniti, A., Mohnl, M., Schatzmayr, G. & Fegeros, K. 2010. Effects of probiotic inclusion levels in broiler nutrition on growth performance, nutrient digestibility, plasma immunoglobulins, and cecal microflora composition. Poultry Science, 89(1): 58–67 .
25. Daskiran, M., Onol, A. G., Cengiz, O., Unsal, H., Turkyilmaz, S., Tatli, O. & Sevim, O. 2012. Influence of dietary probiotic inclusion on growth performance, blood parameters, and intestinal microflora of male broiler chickens exposed to posthatch holding time. Journal of Applied Poultry Research, 21(3): 612–622.
26. Biloni A., Quintana C., Menconi A., Kallapura G., Latorre J., Pixley C., Layton S., Dalmagro M., Hernandez-Velasco, X. & Wolfenden, A. 2013. Evaluation of effects of EarlyBird associated with FloraMax-B11 on Salmonella Enteritidis, intestinal morphology, and performance of broiler chickens. Poultry Science, 92(9): 2337–234
27. Flórez, A.B., Ammor, M.S., Álvarez-Martín, P., Margolles, A. & Mayo, B. 2006. Molecular analysis of tet (W) gene-mediated tetracycline resistance in dominant intestinal Bifidobacterium species from healthy humans. Applied and Environmental Microbiology, 72(11): 7377–7379.
28. Gueimonde, M., Sánchez, B., de los Reyes-Gavilán, C.G. & Margolles, A. 2013. Antibiotic resistance in probiotic bacteria. Frontiers in Microbiology, 4(202): 1–6.
29. Mullany, P., Wilks, M., Lamb, I., Clayton, C., Wren, B. & Tabaqchali, S. 1990. Genetic analysis of a tetracycline resistance element from Clostridium difficile and its conjugal transfer to and from Bacillus subtilis. Journal of General Microbiology, 136(7): 1343–1349.
30. Monod, M., DeNoya, C. & Dubnau, D. 1986. Sequence and properties of pIM13, a macrolide-lincosamide-streptogramin B resistance plasmid from Bacillus subtilis. Journal of Bacteriology, 167(1): 138–147.
31. Gryczan, T., Israeli-Reches, M., Del Bue, M. & Dubnau, D. 1984. DNA sequence and regulation of ermD, a macrolidelincosamide-streptogramin B resistance element from Bacillus licheniformis. Molecular and General Genetics, 194(3): 349–356.
32. Carattoli A. Resista nce plasmid fa mi lies in Enterobacteriaceae // Antimicrob. Agents. Chemother. 2009. Vol. 53. № 6. P. 2227–2238.
33. Supotnitsky M.V. Mechanisms for the development of antibiotic resistance in bacteria//Biologics. 2011. T. 42. № 2. Page 4-44 (InRuss).
34. Probiotics in food: Health and nutritional properties and guidelines for evaluation. FAO Food and Nutrition. 2006. Paper 85.
35. Sanders M.E., Akkermans L.M., Haller D. et al. Safety assessment of probiotics for human use // Gut Microbes. 2010. Vol. 1. № 3. P. 164–185.
36. De Vrese M., Winkler P., Rautenberg P. et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial // Clin. Nutr. 2005. Vol. 24. № 4. P. 481–491.
37. Winkler P., de Vrese M., Laue Ch. et al. Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters // Int. J. Clin. Pharmacol. Ther. 2005. Vol. 43. № 7. P. 318–326.
38. Yamamoto T., Kishida Y., Ishida T. et al. Effect of lactic acid bacteria on intestinally decomposed substance producing bacteria of human source // Basics and Clinics. 1986. Vol. 20. № 14. P. 123.
39. Kalyuzhin O.V. Probiotics as modern means of strengthening anti-infectious immune defenses: myth or reality ?// Russian Medical Journal. 2012. № 28. Page 1395-1401. (InRuss).
40. Wang H.H., Schaffner D.W. Antibiotic resistance: how much do we know and where do we go from here? // Appl. Environ. Microbiol. 2011. Vol. 77. № 20. P. 7093–7095.
41. Wigg A.J., Robert – Thompson J. G., Dymock R.B. The role small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia and tumor necrosis factor – alfa in a pathogenesis of nonalcoholic steatohepatitis. // Gut. – 2001. – Vol. 48. – P. 206 – 211.
42. Rose S. Gastrointestinal and Hepatobiliary pathophysiology. Fence Greek Publishing, LLC, Madison. 1998. 475 p.
43. Yakovenko E.P., Ivanov A.N., Yakovenko A.V. et al.Metabolic liver diseases as systemic manifestations of intestinal dysbacteriosis. The Role of Probiotics in the Normalization of Intestinal Microflora// Regular Issues of "RMW" Russian Medical Journal No. 6 of October 2008 p.396. (In Russ).
44. Mishchenko V.A., Yaremenko N.A., Pavlov D.K. The main reasons for the attrition of highly productive cows//Veterinary. – 2004. – № 10. - S. 15-17. (In Russ).
45. Tilg H., Diehl A. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000; 343 (20): 1467—1476.; Solga S.F., Diehl A. Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J Hepatol 2003; 38: 681—687.
46. Bueverov A.O., Bogomolov P.O., Mayevskaya M.V. Pathogenetic treatment of non-alcoholic steatohepatitis: rationale, effectiveness, safety. Ter archive 2007; 8: 88—92. (In Russ).
47. Loria P., Lonardo A., Carulli L., Verrone A.M., Ricchi M., Lombardini S., Rudilosso A., Ballestri S., Carulli N. Review article: the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2005; 22 (Suppl 2): 31–36.
48. Panina T.V. In Application of a probiotic – a gepatoprotektor “Gepopro” in toxic pathologies of a liver on dogs.//the Thesis for a degree of the candidate of veterinary sciences., 2009. (In Russ).
49. The drawings used in article are taken from the edition "Practical guidance on anti-infectious chemotherapy under L.S. Strachunsky, Y.B. Belousov, S.N. Kozlova. Mechanisms of resistance of microorganisms" (S.V. Sidorenko) Moscow, 2002 © 2000-2007 NIIAH SGMA (In Russ).
Review
For citations:
Sevastianova T.V., Usha B.V. Combined functional additives for farm animals are an important segment in the implementation of the antibiotic resistance strategy and an effective mechanism for restoring animal homeostasis in mixed pathologies. Agrarian science. 2021;354(11-12):8-17. (In Russ.) https://doi.org/10.32634/0869-8155-2021-354-11-12-8-17
Views:
390
Email this article 